Skip to main content
Clinical Trials/CTRI/2018/04/012949
CTRI/2018/04/012949
Completed
未知

Periorbital and ocular surface changes in patients on Prostaglandin Analogue eye drops.

Giridhar Eye Institute0 sites32 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Giridhar Eye Institute
Enrollment
32
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 1, 2018
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients on prostaglandin analogues for less than 6 months irrespective of glaucoma or combination of drugs used.

Exclusion Criteria

  • (a) Patients who has undergone any surgery other than cataract surgery (b) patients already detected with ocular surface diseases (c) patients having lid diseases like ptosis, thyroid related orbitopathy or lid tumours.

Outcomes

Primary Outcomes

Not specified

Similar Trials